-

Dante Genomics Expands into Dante Omics AI: Pioneering the Future of Precision Healthcare

Building on years of innovation—from the Dante Labs Genome to the Avanti Platform—Dante Omics AI introduces fully integrated solutions designed for diagnostics, biopharma and longevity.

original Dante Omics AI (Photo: Business Wire)

Dante Omics AI (Photo: Business Wire)

NEW YORK--(BUSINESS WIRE)--Dante Genomics, a global leader in AI-driven genomic analysis, has expanded into Dante Omics AI to reflect its evolution into a multiomics platform. By integrating genomics, RNA, proteomics, and spatial transcriptomics under one advanced AI framework, Dante Omics AI offers a comprehensive view of human biology, accelerating breakthroughs for clinics, doctors, researchers and biopharma.

The expansion into multiomics started in 2023, pushed by requests by users and customers. The Dante Omics AI team has developed proprietary tools to enhance the benefits of multiomics and integrate different omics data into advanced insights.

“Our users asked us to leverage multiomics and transcend traditional genomics,” said Andrea Riposati, CEO of Dante Omics AI. “By unifying multiomics data and generative AI, we can deliver deeper insights, enhance diagnostics, and personalize patient care at an unprecedented scale.”

Revolutionizing Healthcare Through Multiomics

By delivering a multidimensional view of health, the platform enables precise, data-driven decision-making and more personalized patient care.

Key Features of the Dante Omics AI Platform

  1. Comprehensive Data Integration
    Converges genomics, transcriptomics, proteomics, and metabolomics for a holistic understanding of health.
  2. AI-Powered Insights
    Leverages generative AI for predictive modeling, faster data synthesis, and hypothesis generation.
  3. Advanced Analytics
    Employs machine learning to enhance diagnostic accuracy, drive drug discovery, and advance therapeutic development.
  4. Clinician-Centric Approach
    Offers transparent AI tools that enable precision medicine and informed decision-making.

The platform is currently live and will be rolled out globally in the coming weeks, reaching a wider audience of healthcare providers, researchers, and pharmaceutical innovators. With this expanded reach, Dante Omics AI reaffirms its commitment to pushing the boundaries of precision medicine and accelerating the pace of scientific breakthroughs.

For more information, visit DanteOmics.com.

About Dante Omics AI

Dante Omics AI merges multiomics data with advanced artificial intelligence to drive innovation in precision medicine. The company leverages its proprietary Dante Platform to provide superior results to clinicians, researchers and individuals. The company continues to pioneer cutting-edge technologies that deepen our understanding of human biology and empower transformative healthcare solutions worldwide.

Contacts

Media Contact:
Laura Rossi
+39 0862 191 0671
media@danteomics.com

Industry:

Dante Omics

Details
Headquarters: New York, USA
CEO: Andrea Riposati
Employees: 42
Organization: PRI
Release Versions
EnglishItalian
Hashtags
#AI
#generativeai
#longevity

Contacts

Media Contact:
Laura Rossi
+39 0862 191 0671
media@danteomics.com

Social Media Profiles
Dante Omics AI on LinkedIn
Dante Omics AI YouTube Channel
More News From Dante Omics

Trieste, L'Aquila, Rome: the Italian genomics triangle assembles the new diploid RPE-1 genome, the missing piece for CRISPR, immediately published in California and on Nature magazine – with Dante Labs, Area Science Park, and La Sapienza University

ROME--(BUSINESS WIRE)--A few weeks ago, the USCS Genome Browser at the University of California, Santa Cruz, the bible of reference genomics, published a new and very important reference genome, Diploid RPE-1, key to the study of centromeres, thanks to the work of the Area Science Park in Trieste, the Giunta Lab at Sapienza University, Dante Labs, and the University of L'Aquila. These innovative Italian institutions have formed an international alliance with Rockefeller University in New York a...

From Blurry to 4K DNA: Dante Omics AI, Rockefeller University, Giunta Lab and Global Partners Assemble the Most Complete Genome for the RPE-1 Cell Line – the Standard for Complex Cell Engineering Experiments

NEW YORK--(BUSINESS WIRE)--Dante Omics AI, Rockefeller University, Giunta Lab, Sapienza University, University of Tennessee, Trieste Area Science Park and University of L’Aquila published the successful assembly of a near-complete human diploid reference genome for one of the world’s most widely used cell lines. This breakthrough provides a reference-quality blueprint of the RPE-1 cell line, a workhorse in laboratories around the globe. Dante Omics leveraged its expertise with the Dante Labs ge...

Dante Omics AI Ushers Genomics Into the AI Age With GPU-Accelerated Proprietary Multiomics Platform

NEW YORK--(BUSINESS WIRE)--Dante Omics AI, a pioneering force in computational genomics, today announced a groundbreaking upgrade to its proprietary genome and multiomics alignment, variant calling and reporting platform. The enhanced system leverages cutting-edge NVIDIA GPU technology to deliver unprecedented speed and accuracy in genomic analysis, marking a transformative leap forward in bringing genomics fully into the artificial intelligence age. Revolutionary GPU-Accelerated Genomics Pipel...
Back to Newsroom